These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanistic insight into the relationship between N-terminal acetylation of α-synuclein and fibril formation rates by NMR and fluorescence. Kang L; Janowska MK; Moriarty GM; Baum J PLoS One; 2013; 8(9):e75018. PubMed ID: 24058647 [TBL] [Abstract][Full Text] [Related]
3. Exploring the accessible conformations of N-terminal acetylated α-synuclein. Moriarty GM; Janowska MK; Kang L; Baum J FEBS Lett; 2013 Apr; 587(8):1128-38. PubMed ID: 23499431 [TBL] [Abstract][Full Text] [Related]
4. DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein. Atieh TB; Roth J; Yang X; Hoop CL; Baum J Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680099 [TBL] [Abstract][Full Text] [Related]
5. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions. Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435 [TBL] [Abstract][Full Text] [Related]
6. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein. Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568 [TBL] [Abstract][Full Text] [Related]
13. [Fundamental mechanisms of amyloid fibril formation by alpha-synuclein in Parkinson's disease: quantitative modelling]. Galvagnion C; Buell AK Med Sci (Paris); 2015; 31(6-7):597-600. PubMed ID: 26152159 [No Abstract] [Full Text] [Related]
14. Nucleation of α-Synuclein Amyloid Fibrils Induced by Cross-Interaction with β-Hairpin Peptides Derived from Immunoglobulin Light Chains. Heid LF; Kupreichyk T; Schützmann MP; Schneider W; Stoldt M; Hoyer W Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003322 [TBL] [Abstract][Full Text] [Related]
15. Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein. Ulamec SM; Maya-Martinez R; Byrd EJ; Dewison KM; Xu Y; Willis LF; Sobott F; Heath GR; van Oosten Hawle P; Buchman VL; Radford SE; Brockwell DJ Nat Commun; 2022 Aug; 13(1):4986. PubMed ID: 36008493 [TBL] [Abstract][Full Text] [Related]
16. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth. Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724 [TBL] [Abstract][Full Text] [Related]
17. NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils. Yang X; Wang B; Hoop CL; Williams JK; Baum J Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903234 [TBL] [Abstract][Full Text] [Related]
18. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein. O'Leary EI; Jiang Z; Strub MP; Lee JC J Biol Chem; 2018 Jul; 293(28):11195-11205. PubMed ID: 29853639 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice. Diepenbroek M; Casadei N; Esmer H; Saido TC; Takano J; Kahle PJ; Nixon RA; Rao MV; Melki R; Pieri L; Helling S; Marcus K; Krueger R; Masliah E; Riess O; Nuber S Hum Mol Genet; 2014 Aug; 23(15):3975-89. PubMed ID: 24619358 [TBL] [Abstract][Full Text] [Related]
20. The emerging role of α-synuclein truncation in aggregation and disease. Sorrentino ZA; Giasson BI J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]